A Malaria Vaccine Based on a Sporozoite Antigen
- 9 January 1997
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 336 (2) , 128-130
- https://doi.org/10.1056/nejm199701093360210
Abstract
Malaria was eliminated from many temperate-zone countries in the 1940s, and in the next decade its prevalence was drastically reduced in several tropical countries. However, in recent years, this infection has undergone a resurgence in most tropical regions. Currently, malaria occurs in over 90 countries, and according to World Health Organization estimates, it causes up to 500 million clinical cases and 2.7 million deaths per year. Plasmodium falciparum is the most prevalent of the four malaria parasites of humans and causes most of the severe and lethal infections affecting young children and nonimmune adults. The P. vivax species also causes . . .Keywords
This publication has 12 references indexed in Scilit:
- A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalariaNew England Journal of Medicine, 1997
- Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern ThailandThe Lancet, 1996
- Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity.The Journal of Experimental Medicine, 1996
- The Use of Multiple Antigen Peptides in the Analysis and Induction of Protective Immune Responses against Infectious DiseasesPublished by Elsevier ,1995
- Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.Proceedings of the National Academy of Sciences, 1994
- Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.Proceedings of the National Academy of Sciences, 1993
- Rationale for the Development of an Engineered Sporozoite Malaria VaccinePublished by Elsevier ,1989
- Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium bergheiEuropean Journal of Immunology, 1988
- A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malariaNature, 1988
- Synthetic peptide vaccine confers protection against murine malaria.The Journal of Experimental Medicine, 1987